Skip to Main Content

Insight

December 16, 2025
Cannabis and Psychedelics Monthly Newsletter

the buzz: Cannabis News & Policy Update | December 2025

Welcome back to the buzz, our monthly cannabis news and policy update. Your at-a-glance source for regulatory developments, agency announcements, and trends impacting the cannabis industry.

In this edition of the buzz, highlights include:

  • Major Federal Policy Shift?:  Trump lights-up the industry with talk of Executive Order related to rescheduling.

  • Revisit of Gonzolez v. Raich Rejected:  SCOTUS denies cert. in CannaProvisions case.

  • Federal hemp uncertainty:  CRS warns enforcement of new hemp definition "remains unclear" due to FDA and DEA resource constraints.

  • Medicare expansion:  CMS proposes allowing federally legal hemp products in Medicare plans through November 2026.

  • Tax Court:  Industry coalition files amicus brief in NM Top Organics 280E Tax Court case.

  • DOJ reversal:  Trump administration rescinds Biden marijuana prosecution guidance; Wyoming promises "rigorous" enforcement.

  • New markets:  Florida continues 2026 ballot push; Rhode Island opens first adult-use retail licensing; Texas awards nine medical licenses creating up to 99 locations; Virginia preps 2026 legalization recommendations.

  • State updates:  Colorado adopts final rules benefiting licensees; Michigan court allows 24% wholesale tax to proceed despite ongoing constitutional challenge; Ohio caps retailers at 400, cuts concentrate potency.

  • Hemp patchwork:  Chicago moves toward THC hemp ban; Hawaii advances registration rules; Tennessee extends old framework through June 2026.

Read Here

Want the buzz delivered monthly?
Never miss a cannabis news and policy update. Use the button below to sign up for future monthly newsletters.

Sign Up


Subscribe to get our Insights delivered to your inbox.

This publication is designed to provide general information on pertinent legal topics. The statements made are provided for educational purposes only. They do not constitute legal or financial advice nor do they necessarily reflect the views of Holland & Hart LLP or any of its attorneys other than the author(s). This publication is not intended to create an attorney-client relationship between you and Holland & Hart LLP. Substantive changes in the law subsequent to the date of this publication might affect the analysis or commentary. Similarly, the analysis may differ depending on the jurisdiction or circumstances. If you have specific questions as to the application of the law to your activities, you should seek the advice of your legal counsel.

DISCLAIMER

Unless you are a current client of Holland & Hart LLP, please do not send any confidential information by email. If you are not a current client and send an email to an individual at Holland & Hart LLP, you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us, unless we have already agreed to represent you or we later agree to do so. Thus, we may represent a party adverse to you, even if the information you submit to us could be used against you in a matter, and even if you submitted it in a good faith effort to retain us.